Compound class:
Synthetic organic
Comment: This CCR5 antagonist was designed to overcome some of the detrimental issues associated with the approved CCR5 antagonist maraviroc (an HIV entry inhibitor drug;) such as CYP450 inhibition, hERG inhibition and viral resistance [2]. It is one of the chemical structures claimed in patent WO2015101265A1 belonging to the Shanghai Institute of Materia Medica [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
For advanced searching click here to open chemical structure editor
Similar Ligands ![]() |
|||||||||
|
|